Exact Mass: 555.1246

Exact Mass Matches: 555.1246

Found 30 metabolites which its exact mass value is equals to given mass value 555.1246, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5-[4-(4-Cyanobut-1-yn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)-4-methyl-1H-pyrazole-3-carboxamide

5-[4-(4-cyanobut-1-yn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxo-1lambda6-thiomorpholin-4-yl)-4-methyl-1H-pyrazole-3-carboxamide

C26H23Cl2N5O3S (555.0899)


   
   

N-Fructosyl S-(2-carboxypropyl)glutathione

N-Fructosyl S-(2-carboxypropyl)glutathione

C20H33N3O13S (555.1734)


Annotation level-3

   
   

2, 3, 5-Tribenzoyl; B, HCl-Cytidine

2, 3, 5-Tribenzoyl; B, HCl-Cytidine

C30H25N3O8 (555.1642)


   

1Z,-Isomer-Tunichrome An1|tunichrome B-1|Tunichrome B1

1Z,-Isomer-Tunichrome An1|tunichrome B-1|Tunichrome B1

C26H25N3O11 (555.1489)


   
   

alpha-L-Delta4,5HexpA-(1->3)-beta-D-GalpNAc-(1->4)-D-GlcpA

alpha-L-Delta4,5HexpA-(1->3)-beta-D-GalpNAc-(1->4)-D-GlcpA

C20H29NO17 (555.1435)


   
   

2-Desoxy-[5]adenylsaeure-thymidin-3-ylester|d(TpA)|TA|thymidilyl-(3<*>5)-2-deoxyadenosine|thymidylyl-(3->5)-2-deoxy-adenosine|TpA|TpdA

2-Desoxy-[5]adenylsaeure-thymidin-3-ylester|d(TpA)|TA|thymidilyl-(3<*>5)-2-deoxyadenosine|thymidylyl-(3->5)-2-deoxy-adenosine|TpA|TpdA

C20H26N7O10P (555.1479)


   

4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid

4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid

C25H25N5O6S2 (555.1246)


   

alkali blue 4b

Sodium ((4-((4-amino-m-tolyl)(4-(phenylimino)cyclohexa-2,5-dien-1-ylidene)methyl)phenyl)amino)benzenesulphonate

C32H26N3NaO3S (555.1592)


   

4-[[(2r,3s,4r,5r)-5-[6-Amino-8-[(3,4-Dichlorophenyl)methylamino]purin-9-Yl]-3,4-Dihydroxy-Oxolan-2-Yl]methoxymethyl]benzonitrile

4-[[(2r,3s,4r,5r)-5-[6-Amino-8-[(3,4-Dichlorophenyl)methylamino]purin-9-Yl]-3,4-Dihydroxy-Oxolan-2-Yl]methoxymethyl]benzonitrile

C25H23Cl2N7O4 (555.1188)


VER-155008 is an inhibitor of Hsp70, with IC50s of 0.5 μM, 2.6 μM, and 2.6 μM for Hsp70, Hsc70 and Grp7, respectively, and with a Kd of 0.3 μM for Hsp70.

   
   

S-adenosylglutathione

S-adenosylglutathione

C20H27N8O9S- (555.1622)


   

1-[[(4R,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4R,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4S,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4S,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4R,5R)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4R,5R)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4S,5R)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4S,5R)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4R,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4R,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4R,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4R,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

1-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

1-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea

C23H30BrN3O6S (555.1039)


   

OSMI-2

OSMI-2

C26H25N3O7S2 (555.1134)


OSMI-2 (Compound 1b) is a cell-permeable O-linked N-acetylglucosamine transferase (OGT) inhibitor. Cells contain a large nuclear pool of partially spliced OGT transcript, and OSMI-2 increases detained intron splicing in cells[1].

   

2-amino-3-(3,4,5-trihydroxyphenyl)-n-[2-(3,4,5-trihydroxyphenyl)-1-{[2-(3,4,5-trihydroxyphenyl)ethenyl]carbamoyl}eth-1-en-1-yl]propanimidic acid

2-amino-3-(3,4,5-trihydroxyphenyl)-n-[2-(3,4,5-trihydroxyphenyl)-1-{[2-(3,4,5-trihydroxyphenyl)ethenyl]carbamoyl}eth-1-en-1-yl]propanimidic acid

C26H25N3O11 (555.1489)


   

2-amino-4-{[2-({2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]-2-carboxyethyl}disulfanyl)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[2-({2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]-2-carboxyethyl}disulfanyl)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C18H29N5O11S2 (555.1305)


   

(2s)-2-amino-4-{[(1r)-2-{[(2r)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-carboxyethyl]disulfanyl}-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-2-{[(2r)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-carboxyethyl]disulfanyl}-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C18H29N5O11S2 (555.1305)


   

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-13-methyl-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-13-methyl-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O6 (555.1651)


   

17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-13-methyl-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

17,18-dichloro-3-ethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-13-methyl-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one

C24H31Cl2N5O6 (555.1651)


   

(e,2z)-2-{[(2s)-2-amino-1-hydroxy-3-(3,4,5-trihydroxyphenyl)propylidene]amino}-3-(3,4,5-trihydroxyphenyl)-n-[(1e)-2-(3,4,5-trihydroxyphenyl)ethenyl]prop-2-enimidic acid

(e,2z)-2-{[(2s)-2-amino-1-hydroxy-3-(3,4,5-trihydroxyphenyl)propylidene]amino}-3-(3,4,5-trihydroxyphenyl)-n-[(1e)-2-(3,4,5-trihydroxyphenyl)ethenyl]prop-2-enimidic acid

C26H25N3O11 (555.1489)